1
|
de Oliveira D, Luiz GP, Scussel R, Fagundes MI, Galvani NC, Abel JDS, Zaccaron RP, de Bem Silveira G, de Andrade TAM, Lock Silveira PC, Andrez Machado-de-Ávila R. The combined treatment of gold nanoparticles associated with photobiomodulation accelerate the healing of dermonecrotic lesion. J Drug Target 2024; 32:172-185. [PMID: 38155427 DOI: 10.1080/1061186x.2023.2298848] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2023] [Accepted: 12/10/2023] [Indexed: 12/30/2023]
Abstract
Introduction: The search for fast and efficient treatment for dermonecrotic lesions caused by the venom of the spider from the Loxosceles simillis, is a demand in health. Prednisolone is one of the most used drugs, however it has side effects. In this context, addictionally gold nanoparticles (GNPs) have anti-inflammatory, antioxidant, and antibacterial properties. The use of photobiomodulation has show to be efficient in the process of tissue repair. Therefore, the purpose of this study was to investigate the anti-inflammatory effect of photobiomodulation and GNPs associated or not with a low concentration of prednisolone in animal models of dermonecrotic lesion.Methodology: For this, rabbits with venon-induced dermonecrotic lesion were subjected to topical treatment with prednisolone + laser or GNPs + laser or Pred-GNPs + laser. The area of edema, necrosis and erythema were measured. On the last day of treatment, the animals were euthanized to remove the organs for histopathological and biochemical analysis.Results: All treatments combinations were effective in promoting the reduction of necrotic tissue and erythema.Conclusion: With this results, we suggest that the use of laser and nanoparticles, associated or not with prednisolone, should be considered for the treatment of dermonecrotic injury.
Collapse
Affiliation(s)
- Daysiane de Oliveira
- Postgraduate in Health Sciences, Universidade do Extremo Sul de Catarinense, Criciúma, Santa Catarina, Brazil
| | - Gabriel Paulino Luiz
- Postgraduate in Health Sciences, Universidade do Extremo Sul de Catarinense, Criciúma, Santa Catarina, Brazil
| | - Rahisa Scussel
- Postgraduate in Health Sciences, Universidade do Extremo Sul de Catarinense, Criciúma, Santa Catarina, Brazil
| | - Mirian Ivens Fagundes
- Postgraduate in Health Sciences, Universidade do Extremo Sul de Catarinense, Criciúma, Santa Catarina, Brazil
| | - Nathália Coral Galvani
- Postgraduate in Health Sciences, Universidade do Extremo Sul de Catarinense, Criciúma, Santa Catarina, Brazil
| | - Jessica da Silva Abel
- Postgraduate in Health Sciences, Universidade do Extremo Sul de Catarinense, Criciúma, Santa Catarina, Brazil
| | - Rubya Pereira Zaccaron
- Postgraduate in Health Sciences, Universidade do Extremo Sul de Catarinense, Criciúma, Santa Catarina, Brazil
| | - Gustavo de Bem Silveira
- Postgraduate in Health Sciences, Universidade do Extremo Sul de Catarinense, Criciúma, Santa Catarina, Brazil
| | - Thiago Antônio Moretti de Andrade
- Postgraduate in Biomedical Sciences, University Center of Herminio Ometto Foundation, Postgraduate in Health Sciences, Universidade do Extremo Sul de Catarinense, Criciúma, Santa Catarina, Brazil
| | - Paulo Cesar Lock Silveira
- Postgraduate in Health Sciences, Universidade do Extremo Sul de Catarinense, Criciúma, Santa Catarina, Brazil
| | | |
Collapse
|
2
|
da Silva LE, Abel JS, Tartari G, da Silva MR, de Oliveira MP, Vedova LMD, Mendes TF, Mendes RL, Soares HJ, Vernke CN, Zaccaron RP, Lemos IS, Petronilho F, Silveira PCL, Streck EL, de Ávila RAM, de Mello AH, Rezin GT. Combination of Gold Nanoparticles with Carnitine Attenuates Brain Damage in an Obesity Animal Model. Mol Neurobiol 2024:10.1007/s12035-024-03984-1. [PMID: 38296901 DOI: 10.1007/s12035-024-03984-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2023] [Accepted: 01/21/2024] [Indexed: 02/02/2024]
Abstract
Obesity causes inflammation in the adipose tissue and can affect the central nervous system, leading to oxidative stress and mitochondrial dysfunction. Therefore, it becomes necessary to seek new therapeutic alternatives. Gold nanoparticles (GNPs) could take carnitine to the adipose tissue, thus increasing fatty acid oxidation, reducing inflammation, and, consequently, restoring brain homeostasis. The objective of this study was to investigate the effects of GNPs associated with carnitine on the neurochemical parameters of obesity-induced mice. Eighty male Swiss mice that received a normal lipid diet (control group) or a high-fat diet (obese group) for 10 weeks were used. At the end of the sixth week, the groups were divided for daily treatment with saline, GNPs (70 µg/kg), carnitine (500 mg/kg), or GNPs associated with carnitine, respectively. Body weight was monitored weekly. At the end of the tenth week, the animals were euthanized and the mesenteric fat removed and weighed; the brain structures were separated for biochemical analysis. It was found that obesity caused oxidative damage and mitochondrial dysfunction in brain structures. Treatment with GNPs isolated reduced oxidative stress in the hippocampus. Carnitine isolated decreased the accumulation of mesenteric fat and oxidative stress in the hippocampus. The combination of treatments reduced the accumulation of mesenteric fat and mitochondrial dysfunction in the striatum. Therefore, these treatments in isolation, become a promising option for the treatment of obesity.
Collapse
Affiliation(s)
- Larissa Espindola da Silva
- Laboratory of Neurobiology of Inflammatory and Metabolic Processes, Graduate Program in Health Sciences, Universidade Do Sul de Santa Catarina, Av. José Acácio Moreira, 787, Tubarão, Santa Catarina, SC, 88704-900, Brazil.
| | - Jessica Silva Abel
- Laboratory of Neurobiology of Inflammatory and Metabolic Processes, Graduate Program in Health Sciences, Universidade Do Sul de Santa Catarina, Av. José Acácio Moreira, 787, Tubarão, Santa Catarina, SC, 88704-900, Brazil
| | - Gisele Tartari
- Laboratory of Neurobiology of Inflammatory and Metabolic Processes, Graduate Program in Health Sciences, Universidade Do Sul de Santa Catarina, Av. José Acácio Moreira, 787, Tubarão, Santa Catarina, SC, 88704-900, Brazil
| | - Mariella Reinol da Silva
- Laboratory of Neurobiology of Inflammatory and Metabolic Processes, Graduate Program in Health Sciences, Universidade Do Sul de Santa Catarina, Av. José Acácio Moreira, 787, Tubarão, Santa Catarina, SC, 88704-900, Brazil
| | - Mariana Pacheco de Oliveira
- Laboratory of Neurobiology of Inflammatory and Metabolic Processes, Graduate Program in Health Sciences, Universidade Do Sul de Santa Catarina, Av. José Acácio Moreira, 787, Tubarão, Santa Catarina, SC, 88704-900, Brazil
| | - Larissa Marques Dela Vedova
- Laboratory of Neurobiology of Inflammatory and Metabolic Processes, Graduate Program in Health Sciences, Universidade Do Sul de Santa Catarina, Av. José Acácio Moreira, 787, Tubarão, Santa Catarina, SC, 88704-900, Brazil
| | - Talita Farias Mendes
- Laboratory of Neurobiology of Inflammatory and Metabolic Processes, Graduate Program in Health Sciences, Universidade Do Sul de Santa Catarina, Av. José Acácio Moreira, 787, Tubarão, Santa Catarina, SC, 88704-900, Brazil
| | - Rayane Luiz Mendes
- Laboratory of Neurobiology of Inflammatory and Metabolic Processes, Graduate Program in Health Sciences, Universidade Do Sul de Santa Catarina, Av. José Acácio Moreira, 787, Tubarão, Santa Catarina, SC, 88704-900, Brazil
| | - Hevylin Jacintho Soares
- Laboratory of Neurobiology of Inflammatory and Metabolic Processes, Graduate Program in Health Sciences, Universidade Do Sul de Santa Catarina, Av. José Acácio Moreira, 787, Tubarão, Santa Catarina, SC, 88704-900, Brazil
| | - Camila Nandi Vernke
- Laboratory of Neurobiology of Inflammatory and Metabolic Processes, Graduate Program in Health Sciences, Universidade Do Sul de Santa Catarina, Av. José Acácio Moreira, 787, Tubarão, Santa Catarina, SC, 88704-900, Brazil
| | - Rubya Pereira Zaccaron
- Laboratory of Neurobiology of Inflammatory and Metabolic Processes, Graduate Program in Health Sciences, Universidade Do Sul de Santa Catarina, Av. José Acácio Moreira, 787, Tubarão, Santa Catarina, SC, 88704-900, Brazil
| | - Isabela Silva Lemos
- Laboratory of Neurometabolic Diseases, Graduate Program in Health Sciences, Universidade Do Extremo Sul Catarinense, Criciuma, SC, Brazil
| | - Fabricia Petronilho
- Laboratory of Experimental Neurology, Graduate Program in Health Sciences, Universidade Do Extremo Sul Catarinense, Criciuma, SC, Brazil
| | - Paulo Cesar Lock Silveira
- Pathophysiology Laboratory, Graduate Program in Health Sciences, Universidade Do Extremo Sul Catarinense, Criciuma, SC, Brazil
| | - Emilio Luiz Streck
- Laboratory of Neurometabolic Diseases, Graduate Program in Health Sciences, Universidade Do Extremo Sul Catarinense, Criciuma, SC, Brazil
| | - Ricardo Andrez Machado de Ávila
- Pathophysiology Laboratory, Graduate Program in Health Sciences, Universidade Do Extremo Sul Catarinense, Criciuma, SC, Brazil
| | - Aline Haas de Mello
- Department of Pediatrics, The University of Texas Medical Branch, Galveston, TX, USA
| | - Gislaine Tezza Rezin
- Laboratory of Neurobiology of Inflammatory and Metabolic Processes, Graduate Program in Health Sciences, Universidade Do Sul de Santa Catarina, Av. José Acácio Moreira, 787, Tubarão, Santa Catarina, SC, 88704-900, Brazil
| |
Collapse
|
3
|
Abelaira HM, de Moura AB, Cardoso MM, de Pieri E, Abel JS, Luiz GP, Sombrio EM, Borghezan LA, Anastácio RS, Cruz LA, de Souza TG, Meab C, Lima IR, da Costa C, Dal Bó AG, Pcl S, Machado-de-Ávila RA. Sertraline associated with gold nanoparticles reduce cellular toxicity and induce sex-specific responses in behavior and neuroinflammation biomarkers in a mouse model of anxiety. Pharmacol Biochem Behav 2023; 233:173661. [PMID: 37879445 DOI: 10.1016/j.pbb.2023.173661] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/21/2023] [Revised: 10/20/2023] [Accepted: 10/22/2023] [Indexed: 10/27/2023]
Abstract
This study aimed to evaluate the effects of sertraline associated with gold nanoparticles (AuNPs) in vitro cell viability and in vivo behavior and inflammatory biomarkers in a mouse model of anxiety. Sertraline associated with AuNPs were synthesized and characterized. For the in vitro study, NIH3T3 and HT-22 cells were treated with different doses of sertraline, AuNPs, and sertraline + AuNPs and their viability was evaluated using the MTT assay. For the in vivo study, pregnant Swiss mice were administered a single dose of lipopolysaccharide (LPS) on the ninth day of gestation. The female and male offspring were divided into five treatment groups on PND 60 and administered chronic treatment for 28 days. The animals were subjected to behavioral testing and were subsequently euthanized. Their brains were collected and analyzed for inflammatory biomarkers. Sertraline associated with AuNPs exhibited significant changes in surface characteristics and increased diameters. Different doses of sertraline + AuNPs showed higher cell viability in NIH3T3 and HT-22 cells compared with sertraline alone. The offspring of LPS-treated dams exhibited anxiety-like behavior and neuroinflammatory biomarker changes during adulthood, which were ameliorated via sertraline + AuNPs treatment. The treatment response was sex-dependent and brain region-specific. These results suggest that AuNPs, which demonstrate potential to bind to other molecules, low toxicity, and reduced inflammation, can be synergistically used with sertraline to improve drug efficacy and safety by decreasing neuroinflammation and sertraline toxicity.
Collapse
Affiliation(s)
- H M Abelaira
- Laboratory of Pathophysiology Experimental, Postgraduate Program in Health Sciences, Universidade do Extremo Sul Catarinense (UNESC), Criciúma, SC, Brazil.
| | - A B de Moura
- Laboratory of Pathophysiology Experimental, Postgraduate Program in Health Sciences, Universidade do Extremo Sul Catarinense (UNESC), Criciúma, SC, Brazil
| | - M M Cardoso
- Laboratory of Pathophysiology Experimental, Postgraduate Program in Health Sciences, Universidade do Extremo Sul Catarinense (UNESC), Criciúma, SC, Brazil
| | - E de Pieri
- Laboratory of Pathophysiology Experimental, Postgraduate Program in Health Sciences, Universidade do Extremo Sul Catarinense (UNESC), Criciúma, SC, Brazil
| | - J S Abel
- Laboratory of Pathophysiology Experimental, Postgraduate Program in Health Sciences, Universidade do Extremo Sul Catarinense (UNESC), Criciúma, SC, Brazil
| | - G P Luiz
- Laboratory of Pathophysiology Experimental, Postgraduate Program in Health Sciences, Universidade do Extremo Sul Catarinense (UNESC), Criciúma, SC, Brazil
| | - E M Sombrio
- Laboratory of Pathophysiology Experimental, Postgraduate Program in Health Sciences, Universidade do Extremo Sul Catarinense (UNESC), Criciúma, SC, Brazil
| | - L A Borghezan
- Laboratory of Pathophysiology Experimental, Postgraduate Program in Health Sciences, Universidade do Extremo Sul Catarinense (UNESC), Criciúma, SC, Brazil
| | - R S Anastácio
- Laboratory of Pathophysiology Experimental, Postgraduate Program in Health Sciences, Universidade do Extremo Sul Catarinense (UNESC), Criciúma, SC, Brazil
| | - L A Cruz
- Laboratory of Pathophysiology Experimental, Postgraduate Program in Health Sciences, Universidade do Extremo Sul Catarinense (UNESC), Criciúma, SC, Brazil
| | - T G de Souza
- Laboratory of Pathophysiology Experimental, Postgraduate Program in Health Sciences, Universidade do Extremo Sul Catarinense (UNESC), Criciúma, SC, Brazil
| | - Corrêa Meab
- Laboratory of Pathophysiology Experimental, Postgraduate Program in Health Sciences, Universidade do Extremo Sul Catarinense (UNESC), Criciúma, SC, Brazil
| | - I R Lima
- Laboratory of Pathophysiology Experimental, Postgraduate Program in Health Sciences, Universidade do Extremo Sul Catarinense (UNESC), Criciúma, SC, Brazil
| | - C da Costa
- Laboratory of Pathophysiology Experimental, Postgraduate Program in Health Sciences, Universidade do Extremo Sul Catarinense (UNESC), Criciúma, SC, Brazil
| | - A G Dal Bó
- Laboratory of Advanced Polymer Processing, Universidade do Extremo Sul Catarinense (UNESC), Criciúma, SC, Brazil
| | - Silveira Pcl
- Laboratory of Pathophysiology Experimental, Postgraduate Program in Health Sciences, Universidade do Extremo Sul Catarinense (UNESC), Criciúma, SC, Brazil
| | - R A Machado-de-Ávila
- Laboratory of Pathophysiology Experimental, Postgraduate Program in Health Sciences, Universidade do Extremo Sul Catarinense (UNESC), Criciúma, SC, Brazil
| |
Collapse
|